Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Allergic bronchopulmonary aspergillosis].

F Salez1, C Lamblin, B Wallaert

  • 1Clinique des Maladies Respiratoires, Hopital A.-Calmette, Lille.

Revue Des Maladies Respiratoires
|July 21, 2000
PubMed
Summary

Allergic bronchopulmonary aspergillosis (ABPA) is an immune condition caused by Aspergillus fumigatus. Early diagnosis and treatment with prednisone and antifungals are key to managing asthma and preventing disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Physical activity and pulmonary rehabilitation in adults with asthma].

Revue des maladies respiratoires·2021
Same author

Recurrence of chilblains during a second contact with SARS-CoV-2: a case report.

The British journal of dermatology·2021
Same author

Expectations about treatment of idiopathic pulmonary fibrosis: Comparative survey of patients, carers and physicians (the RESPIR French survey).

Respiratory medicine and research·2021
Same author

The 1-minute sit-to-stand test to evaluate quadriceps muscle strength in patients with interstitial lung disease.

Respiratory medicine and research·2020
Same author

Pulmonary rehabilitation and daily life physical activity in patients with stage IV sarcoidosis.

Respiratory medicine and research·2020
Same author

Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients.

Orphanet journal of rare diseases·2020

Area of Science:

  • Pulmonology
  • Immunology
  • Infectious Diseases

Context:

  • Allergic bronchopulmonary aspergillosis (ABPA) is an immune-mediated lung inflammation.
  • It results from an adverse immune response to Aspergillus fumigatus in the lower respiratory tract.

Purpose:

  • To outline the key clinical features, diagnostic considerations, disease stages, and treatment goals for ABPA.
  • To emphasize the importance of considering ABPA in asthmatics of all ages.

Summary:

  • ABPA presents with asthma, pulmonary infiltrates, skin reactivity to A. fumigatus, elevated IgE, eosinophilia, and central bronchiectasis.
  • The disease progresses through five stages, from acute to fibrotic, potentially leading to pulmonary fibrosis and respiratory insufficiency.
  • Treatment focuses on asthma control and ABPA exacerbation prevention, involving prednisone for acute stages and antifungals like itraconazole.

Impact:

  • Facilitates timely diagnosis and management of ABPA across all age groups.
  • Provides a framework for understanding the natural history and therapeutic strategies for ABPA.
  • Aims to improve patient outcomes by controlling asthma and mitigating disease severity.

Related Experiment Videos